Cantourage Unveils New Medical Cannabis Brand in Germany

Cantourage, a prominent player in the European medical cannabis sector, has introduced its first proprietary brand, gramz., to the German market. This launch represents a pivotal move for Cantourage as it integrates its global sourcing, branding, and pharmaceutical distribution expertise into a cohesive market offering.

The gramz. line features high-quality medical cannabis sourced from reputable international partners, offered at competitive prices. Initial market response was robust, with the first product batches rapidly selling out to German pharmacies within two days, highlighting strong demand.

The new brand reflects Cantourage's strategic focus on consistent quality and competitive pricing. Patrick Malessa, Marketing Director, emphasized the importance of aligning quality, cost, and brand integrity to build a sustainable brand.

Going forward, Cantourage plans to expand its product range and enhance its telemedicine services, leveraging its extensive supply chain and digital infrastructure to maintain a competitive edge in the evolving European market.